4-HYDROXYANDROSTENEDIONE IN TREATMENT OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCER

This publication has 10 references indexed in Scilit:

• Aromatase: A Target Enzyme in Breast Cancer
  Published by Elsevier ,1984
• Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo
  Steroids, 1981
• ASSESSMENT OF BIOCHEMICAL TESTS TO SCREEN FOR METASTASES IN PATIENTS WITH BREAST CANCER*1
  The Lancet, 1980
• Inhibition of Peripheral Aromatization by Aromatase Inhibitors, 4-Hydroxy- and 4-Acetoxy-Androstene-3,17 Dione*
  Endocrinology, 1980
• The Effect of an Aromatase Inhibitor, 4-Hydroxy-4-Androstene- 3,17-Dione, On Estrogen-Dependent Processes in Reproduction and Breast Cancer¹¹
  Endocrinology, 1977
• Assessment of response to therapy in advanced breast cancer.A project of the programme on clinical oncology of the International Union against Cancer, Geneva, Switzerland
  Cancer, 1977
• Studies of human placental aromatase
  Journal of Steroid Biochemistry, 1975
• IMPROVED SENSITIVITY: IN THE MEASUREMENT OF ESTROGEN RECEPTOR IN HUMAN BREAST CANCER
  Journal of Clinical Endocrinology & Metabolism, 1973
• Studies on the Mechanism of Estrogen Biosynthesis. VIII. The Development of Inhibitors of the Enzyme System in Human Placenta1
  Endocrinology, 1973
• Metabolic clearance and blood production rates of estrogens in postmenopausal women
  American Journal of Obstetrics and Gynecology, 1971